Prostacycline Vasodilator drugs compared
Compare all 4 Prostacycline Vasodilator drugs side by side, used for conditions such as hypertension, pulmonary. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 4 drugs
- 168/100
treprostinil
Treprostinil
- 2New
tyvaso
Treprostinil
- 3New
tyvaso dpi
Treprostinil
- 4New
yutrepia
Treprostinil Sodium
Frequently asked questions
What is the Prostacycline Vasodilator drug class?
Prostacycline Vasodilator is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Prostacycline Vasodilator products, each independently rated.
Are all Prostacycline Vasodilator drugs the same?
No. Prostacycline Vasodilator drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Prostacycline Vasodilator drugs treat?
Per NIH RxClass drug-classification data, Prostacycline Vasodilator drugs are used for conditions including hypertension, pulmonary.
Sources: the Prostacycline Vasodilator class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.